Drugs
LYON, FRANCE: LYON, FRANCE -- (Marketwired) -- 09/11/13 -- In the news release, "Flamel Technologies Announces Acceptance of FDA Review for Second NDA," issued earlier today by Flamel Technologies (NASDA ...
LYON, FRANCE: LYON, FRANCE -- (Marketwired) -- 09/11/13 -- Flamel Technologies S.A. (NASDAQ: FLML) today announced that the US Food and Drug Administration (FDA) has accepted for review the Company's second n ...
DENVER, CO: Positive Results for Solo I and Solo II Trial of Oritavancin in Acute Bacterial Skin and Skin Structure Infections Including MRSA ...
CONSHOHOCKEN, PA: CONSHOHOCKEN, PA -- (Marketwired) -- 09/10/13 -- (NASDAQ: PATH) today announced that the United States Patent and Trademark Office has issued a notice of allowance for U.S. Patent application 13/407 ...
TORONTO, ON: TORONTO, ON -- (Marketwired) -- 09/09/13 -- Axxess Pharma Inc. (PINKSHEETS: AXXE), a specialty pharmaceutical and nutritional supplements company, is pleased to announce they have signed an agreement ...
MANCHESTER, NH: MANCHESTER, NH -- (Marketwired) -- 09/09/13 -- Boston Therapeutics, Inc. (OTCQB: BTHE) ("Boston Therapeutics" or "the Company"), a developer of drugs based on complex carbohydrate ...
SAN DIEGO, CA: SAN DIEGO, CA -- (Marketwired) -- 09/06/13 -- Vital Therapies®, Inc. (VTI), a biopharmaceutical company developing a cell-based therapy targeting the treatment of acute liver failure, today announce ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 09/05/13 -- Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) today announced that Barry Selick, Ph.D., Threshold's Chief Executive Officer, will present ...
TORONTO, ON: Dr. Maese Brings Forth Strong Medical Following via His Established Radio Shows ...
CONSHOHOCKEN, PA: CONSHOHOCKEN, PA -- (Marketwired) -- 09/04/13 -- (NASDAQ: PATH) will present a company overview at the Stifel 2013 Healthcare Conference on Wednesday, September 11, 2013, at 4:25 p.m. EDT. The confe ...
TORONTO, ON: TORONTO, ON -- (Marketwired) -- 09/02/13 -- Axxess Pharma Inc. (PINKSHEETS: AXXE), a specialty pharmaceutical and nutritional supplements company, today announced an Agreement in Principle to acquire ...
CARLSBAD, CA: CARLSBAD, CA -- (Marketwired) -- 08/28/13 -- International Stem Cell Corporation (OTCQB: ISCO) (), a California-based biotechnology company developing novel stem cell based therapies and biomedical p ...
MILAN, ITALY: MILAN, ITALY -- (Marketwired) -- 08/27/13 --Contacts:
RNS
Customer
Services
0044-207797-4400 ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 08/19/13 -- Xylitol Canada Inc. ("Xylitol Canada", or the "Company") (TSX VENTURE: XYL) today announces that it has released its financial an ...
SAN DIEGO, CA: SAN DIEGO, CA -- (Marketwired) -- 08/19/13 -- Seragon Pharmaceuticals Inc. today announced its formation and the closing of its Series A financing. Seragon is focused on developing new treatments for ...
LAS VEGAS, NV: LAS VEGAS, NV -- (Marketwired) -- 08/19/13 -- PharmaRoth Labs, Inc. (OTC Pink: ROTH), the exclusive producer and marketer of Sucanon®, an oral Type-II Diabetes treatment, announced that it has shipp ...
MONTREAL, CANADA: MONTREAL, CANADA -- (Marketwired) -- 08/19/13 -- Paladin Labs Inc. (TSX: PLB), a leading Canadian specialty pharmaceutical company, announced today the launch of Emtrix®, a unique over-the-counter ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 08/19/13 -- (TSX VENTURE: SBM) () (FRANKFURT: ZSB) announced today the signing of a Letter of Intent whereby Sirona Biochem will provide an exclusive ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 08/16/13 -- Xylitol Canada Inc. ("Xylitol Canada", or the "Company") (TSX VENTURE: XYL) announces today that pursuant to the terms of its sto ...
